作者
Can Cao,Hye Jin Kang,Isha Singh,He Chen,Chengwei Zhang,Wenlei Ye,Byron W. Hayes,Jing Liu,Ryan H. Gumpper,Brian J. Bender,Samuel T. Slocum,B. Krumm,Katherine Lansu,John D. McCorvy,Wesley K. Kroeze,Justin G. English,Jeffrey F. DiBerto,Reid H. J. Olsen,Xi‐Ping Huang,Shicheng Zhang,Yongfeng Liu,Kuglae Kim,Joel Karpiak,Lily Yeh Jan,Soman N. Abraham,Jian Jin,Brian K. Shoichet,Jonathan F. Fay,Bryan L. Roth
摘要
The MRGPRX family of receptors (MRGPRX1–4) is a family of mas-related G-protein-coupled receptors that have evolved relatively recently1. Of these, MRGPRX2 and MRGPRX4 are key physiological and pathological mediators of itch and related mast cell-mediated hypersensitivity reactions2–5. MRGPRX2 couples to both Gi and Gq in mast cells6. Here we describe agonist-stabilized structures of MRGPRX2 coupled to Gi1 and Gq in ternary complexes with the endogenous peptide cortistatin-14 and with a synthetic agonist probe, respectively, and the development of potent antagonist probes for MRGPRX2. We also describe a specific MRGPRX4 agonist and the structure of this agonist in a complex with MRGPRX4 and Gq. Together, these findings should accelerate the structure-guided discovery of therapeutic agents for pain, itch and mast cell-mediated hypersensitivity. Structural studies of the itch receptors MRGPRX2 and MRGPRX4 in complex with endogenous and synthetic ligands provide a basis for the development of therapeutic compounds for pain, itch and mast cell-mediated hypersensitivity.